Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate with Vitamin B12 and Folic Acid in Relapsed/Refractory PTCL
NCT03349333Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Sep 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pralatrexate in peripheral T-cell lymphoma (PTCL), sponsored by Mundipharma. Started Sep 2015; status: completed.
02
Drugs
pralatrexate
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03349333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349333.